| __timestamp | Amneal Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 785623000 | 1777824000000 |
| Thursday, January 1, 2015 | 866280000 | 1807378000000 |
| Friday, January 1, 2016 | 1018225000 | 1732051000000 |
| Sunday, January 1, 2017 | 1033654000 | 1770531000000 |
| Monday, January 1, 2018 | 1662991000 | 2097224000000 |
| Tuesday, January 1, 2019 | 1626373000 | 3291188000000 |
| Wednesday, January 1, 2020 | 1992523000 | 3197812000000 |
| Friday, January 1, 2021 | 2093669000 | 3569006000000 |
| Saturday, January 1, 2022 | 2212304000 | 4027478000000 |
| Sunday, January 1, 2023 | 2393607000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Takeda Pharmaceutical Company Limited and Amneal Pharmaceuticals, Inc. have showcased contrasting revenue trajectories. Takeda, a Japanese multinational, has consistently outperformed its American counterpart, Amneal, with revenues peaking at approximately $4.26 trillion in 2023. This represents a staggering 140% increase from its 2014 figures. In contrast, Amneal's revenue growth has been more modest, with a 205% increase over the same period, reaching around $2.39 billion in 2023. Despite Amneal's impressive growth rate, Takeda's sheer scale and market reach highlight its dominance in the industry. Notably, data for 2024 is incomplete, leaving room for speculation on future trends. As these companies continue to innovate, their financial trajectories will be closely watched by investors and industry analysts alike.
Revenue Showdown: AstraZeneca PLC vs Takeda Pharmaceutical Company Limited
Novartis AG vs Takeda Pharmaceutical Company Limited: Annual Revenue Growth Compared
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Takeda Pharmaceutical Company Limited or Merus N.V.?
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Supernus Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited and Novavax, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: Walgreens Boots Alliance, Inc. and Amneal Pharmaceuticals, Inc. Performance Compared
Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Amneal Pharmaceuticals, Inc. vs Mesoblast Limited: Examining Key Revenue Metrics